ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,210.40
      0.24%
      Dow Jones
      39,118.86
      0.00%
      Brent Oil
      85.555
      0.52%
      Bitcoin
      62,649.92
      0.08%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. NGM Biopharmaceuticals Inc (NGM)

      7. NGM Biopharmaceuticals Inc (NGM) News

      NGM

      NGM Biopharmaceuticals (NGM)

      NGM Biopharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:NGM
      DateTimeSourceHeadlineSymbolCompany
      12/16/20204:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      12/09/20204:05PMGlobeNewswire Inc.NGM Discloses Third Oncology Development Candidate, NGM438, a Novel Antagonist Antibody Inhibiting LAIR1 for the Treatment of...NASDAQ:NGMNGM Biopharmaceuticals Inc
      11/20/20204:37PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NGMNGM Biopharmaceuticals Inc
      11/16/202012:05PMGlobeNewswire Inc.NGM to Host Virtual R&D Day on December 9, 2020NASDAQ:NGMNGM Biopharmaceuticals Inc
      11/13/20208:00AMGlobeNewswire Inc.NGM Bio Presents Phase 1 Safety and Pharmacokinetics Data for NGM621, an Anti-Complement C3 Antibody, in Patients with Geogra...NASDAQ:NGMNGM Biopharmaceuticals Inc
      11/12/20204:38PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NGMNGM Biopharmaceuticals Inc
      11/12/20204:34PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NGMNGM Biopharmaceuticals Inc
      11/12/20204:05PMGlobeNewswire Inc.NGM Bio Provides Business Highlights and Reports Third Quarter 2020 Financial ResultsNASDAQ:NGMNGM Biopharmaceuticals Inc
      11/11/20208:00AMGlobeNewswire Inc.NGM Bio to Present at Three Upcoming Investor ConferencesNASDAQ:NGMNGM Biopharmaceuticals Inc
      11/05/20208:00AMGlobeNewswire Inc.NGM Bio to Present Safety and Pharmacokinetics Data from Phase 1 Study of NGM621 in Patients with Geographic Atrophy at Ameri...NASDAQ:NGMNGM Biopharmaceuticals Inc
      11/04/20205:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      11/04/20208:00AMGlobeNewswire Inc.NGM Bio Announces Multiple Aldafermin Presentations at Upcoming AASLD The Liver Meeting®, including Late-Breaking Oral Prese...NASDAQ:NGMNGM Biopharmaceuticals Inc
      10/19/20207:00AMGlobeNewswire Inc.NGM Expands Oncology Portfolio with First Immuno-Oncology Development Candidate, NGM707, a Novel Dual Antagonist Antibody Inh...NASDAQ:NGMNGM Biopharmaceuticals Inc
      10/13/20205:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      09/03/20205:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      09/03/20204:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      08/31/20205:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      08/29/20207:20AMGlobeNewswire Inc.NGM Bio Presents Comprehensive Findings from 24-Week Phase 2 Study (Cohort 4) of Aldafermin in Oral Plenary Presentation at T...NASDAQ:NGMNGM Biopharmaceuticals Inc
      08/25/20206:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      08/25/20206:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      08/18/20208:00AMGlobeNewswire Inc.NGM Bio Announces Oral Plenary Presentation of 24-Week Phase 2 Study (Cohort 4) of Aldafermin in Patients with NASH at The D...NASDAQ:NGMNGM Biopharmaceuticals Inc
      08/17/20207:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      08/17/20207:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      08/12/20204:16PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NGMNGM Biopharmaceuticals Inc
      08/12/20204:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NGMNGM Biopharmaceuticals Inc
      08/12/20204:05PMGlobeNewswire Inc.NGM Bio Provides Business Highlights and Reports Second Quarter 2020 Financial ResultsNASDAQ:NGMNGM Biopharmaceuticals Inc
      08/11/20204:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      08/03/20205:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      08/03/20205:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NGMNGM Biopharmaceuticals Inc
      07/31/20208:00AMGlobeNewswire Inc.NGM Bio to Present at Two Upcoming Investor ConferencesNASDAQ:NGMNGM Biopharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:NGM